4 Matching Annotations
  1. Last 7 days
    1. Von Hippel-Lindau disease (VHL) is an autosomal dominantly inherited disorder due to a mutation in a tumor-suppressor gene (VHLgene), localized in the 3th chromosome. It is characterized by the presence of more than 2 different tumors, including hemangioblastomas of the brain, spinal cord and retina; pancreatic cysts or pancreatic islet cell tumors; renal cysts and renal cell carcinoma; benign epididymal cystadenomas. Frequency of the described tumors varies widely in different families. About 10-20 % of all patients with VHL disease develop pheochromocytomas, characterized by significantly earlier occurrence, more frequently with multifocal localization and associated with a relatively lower frequency of malignancy compared to sporadic forms. There is a marked genotype–phenotype correlation – four phenotypic subclasses of VHL disease have been distinguished. The most problematic in clinical practice is subclass 2С, which is characterized by a phaeochromocytoma-only phenotype and is often misdiagnosed as a sporadic pheochromocytoma. We present a clinical case of a familial bilateral pheochromocytoma as the sole feature of the von Hippel-Lindau disease. This is the first family with this disorder described in our country. Performing a genetic analysis, a missence mutation – c.499 C>T(p.Arg167Trp) in exon 3 of the VHL-gene was identified.

      PatientID: III-1

      KindredID: 1

      Case: F, 4Y0M, Southern European (Bulgarian)

      DiseaseAssertion: asymptomatic

      FamilyInfo: Familial case from Bulgaria of bilateral pheochromocytoma. Her dad, uncle, and grandmother were all affected with the gene.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: Asymptomatic likely due to young age (born 2003).

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: N/A

      MultipleGeneVariants: N/A

    2. Von Hippel-Lindau disease (VHL) is an autosomal dominantly inherited disorder due to a mutation in a tumor-suppressor gene (VHLgene), localized in the 3th chromosome. It is characterized by the presence of more than 2 different tumors, including hemangioblastomas of the brain, spinal cord and retina; pancreatic cysts or pancreatic islet cell tumors; renal cysts and renal cell carcinoma; benign epididymal cystadenomas. Frequency of the described tumors varies widely in different families. About 10-20 % of all patients with VHL disease develop pheochromocytomas, characterized by significantly earlier occurrence, more frequently with multifocal localization and associated with a relatively lower frequency of malignancy compared to sporadic forms. There is a marked genotype–phenotype correlation – four phenotypic subclasses of VHL disease have been distinguished. The most problematic in clinical practice is subclass 2С, which is characterized by a phaeochromocytoma-only phenotype and is often misdiagnosed as a sporadic pheochromocytoma. We present a clinical case of a familial bilateral pheochromocytoma as the sole feature of the von Hippel-Lindau disease. This is the first family with this disorder described in our country. Performing a genetic analysis, a missence mutation – c.499 C>T(p.Arg167Trp) in exon 3 of the VHL-gene was identified.

      PatientID: II-3

      KindredID: 1

      Case: M, 30Y0M (deceased), Southern European (Bulgarian)

      DiseaseAssertion: adrenal pheochromocytoma

      FamilyInfo: Familial case from Bulgaria of bilateral pheochromocytoma. His mother and brother were affected, as well as his niece.

      CasePresentingHPOs: HP:0006748 (adrenal pheochromocytoma)

      CaseHPOFreeText: Presented at 18Y with bilateral pheochromocytoma, and later passed away (born 1977). He presented with the same clinical features as his brother: bilateral tumors of the adrenal glands.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: N/A

      MultipleGeneVariants: N/A

    3. Von Hippel-Lindau disease (VHL) is an autosomal dominantly inherited disorder due to a mutation in a tumor-suppressor gene (VHLgene), localized in the 3th chromosome. It is characterized by the presence of more than 2 different tumors, including hemangioblastomas of the brain, spinal cord and retina; pancreatic cysts or pancreatic islet cell tumors; renal cysts and renal cell carcinoma; benign epididymal cystadenomas. Frequency of the described tumors varies widely in different families. About 10-20 % of all patients with VHL disease develop pheochromocytomas, characterized by significantly earlier occurrence, more frequently with multifocal localization and associated with a relatively lower frequency of malignancy compared to sporadic forms. There is a marked genotype–phenotype correlation – four phenotypic subclasses of VHL disease have been distinguished. The most problematic in clinical practice is subclass 2С, which is characterized by a phaeochromocytoma-only phenotype and is often misdiagnosed as a sporadic pheochromocytoma. We present a clinical case of a familial bilateral pheochromocytoma as the sole feature of the von Hippel-Lindau disease. This is the first family with this disorder described in our country. Performing a genetic analysis, a missence mutation – c.499 C>T(p.Arg167Trp) in exon 3 of the VHL-gene was identified.

      PatientID: II-1

      KindredID: 1

      Case: M, 33Y0M, Southern European (Bulgarian)

      DiseaseAssertion: adrenal pheochromocytoma

      FamilyInfo: Familial case from Bulgaria of bilateral pheochromocytoma. His mother and brother were affected, and he has passed the gene onto his daughter.

      CasePresentingHPOs: HP:0006748 (adrenal pheochromocytoma)

      CaseHPOFreeText: Affected with bilateral pheochromocytoma (born 1974). Brought into hospital at 12Y with arterial hypertension (suggestive of symptomatic endocrine hypertension in pheochromocytoma). These were operated on. He relapsed twice, years later.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: N/A

      MultipleGeneVariants: N/A

    4. Von Hippel-Lindau disease (VHL) is an autosomal dominantly inherited disorder due to a mutation in a tumor-suppressor gene (VHLgene), localized in the 3th chromosome. It is characterized by the presence of more than 2 different tumors, including hemangioblastomas of the brain, spinal cord and retina; pancreatic cysts or pancreatic islet cell tumors; renal cysts and renal cell carcinoma; benign epididymal cystadenomas. Frequency of the described tumors varies widely in different families. About 10-20 % of all patients with VHL disease develop pheochromocytomas, characterized by significantly earlier occurrence, more frequently with multifocal localization and associated with a relatively lower frequency of malignancy compared to sporadic forms. There is a marked genotype–phenotype correlation – four phenotypic subclasses of VHL disease have been distinguished. The most problematic in clinical practice is subclass 2С, which is characterized by a phaeochromocytoma-only phenotype and is often misdiagnosed as a sporadic pheochromocytoma. We present a clinical case of a familial bilateral pheochromocytoma as the sole feature of the von Hippel-Lindau disease. This is the first family with this disorder described in our country. Performing a genetic analysis, a missence mutation – c.499 C>T(p.Arg167Trp) in exon 3 of the VHL-gene was identified.

      PatientID: I-2

      KindredID: 1

      Case: F, 55Y0M, Southern European (Bulgarian)

      DiseaseAssertion: asymptomatic

      FamilyInfo: Familial case from Bulgaria of bilateral pheochromocytoma. She had 3 children, 2 of which were affected by this gene, and one grandchild affected

      CasePresentingHPOs: N/A

      CaseHPOFreeText: Born 1952 - no phenotypes reported (possibly an asymptomatic carrier)

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: N/A

      MultipleGeneVariants: N/A